Cetera Investment Advisers
NXL icon

Cetera Investment Advisers’s Nexalin Technology NXL Stock Holding History

Cetera Investment Advisers’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,000
Closed -$9.37K – 3859
2024
Q3 		$9.37K Buy
+14,000
New +$14.4K ﹤0.01% 3671

Other funds holding NXL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Cetera Investment Advisers's NXL Position: Q4 2024 in Review

Cetera Investment Advisers sold out of Nexalin Technology (NXL) in Q4 2024, closing a stake of 14,000 shares — an estimated $9.37K sold.

Cetera Investment Advisers first reported a position in NXL in Q3 2024 and held it in 1 quarter. The position peaked at $9.37K in Q3 2024. 19 funds tracked by Wall St. Rank hold NXL as of Q4 2024.

  • Cetera Investment Advisers reported no remaining Nexalin Technology position as of Q4 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 14,000 Nexalin Technology shares in Q4 2024, an estimated $9.37K.
  • Cetera Investment Advisers first reported a position in Nexalin Technology in Q3 2024 and held it in 1 quarter.
  • Cetera Investment Advisers's Nexalin Technology position peaked at $9.37K in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Nexalin Technology as of Q4 2024.

Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.